drugset / Trial / NCT04992026
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
Phase 2
Completed
130 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Affiliated Hospital of Nantong University · collabThe Affiliated Hospital of Xuzhou Medical University · collabThe First Affiliated Hospital of Soochow University · collabThe First People's Hospital of Changzhou · collabWuxi People's Hospital · collabYangzhou University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized, controlled, multi-center clinical trial aims to evaluate the efficacy and safety of prostatectomy for castration-Naive oligometastatic prostate cancer
Timeline
- Start
- 2021-01-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Abiraterone acetate | Small molecule | 1000 mg | — |
| Background | Goserelin | Other / unclassified | — | Subcutaneous |
| Background | Leuprolide | Other / unclassified | — | Subcutaneous |
| Background | Prednisone | Other / unclassified | 5 mg | Oral |
| Background | Triptorelin | Other / unclassified | — | Subcutaneous |